EcoDrugPlus

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSBMUG00000001320
Gene Symbol: LOC102270532
2 Cross references
206 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSBMUG00000018690
Gene Symbol: SRD5A2
3 Cross references
266 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSBMUG00000014342
Gene Symbol: SOAT1
3 Cross references
211 Possible Orthologues:

Sucrase-Isomaltase

Ensembl ID : ENSBMUG00000014232
Gene Symbol: SI
3 Cross references
201 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSBMUG00000025057
Gene Symbol: SNCA
3 Cross references
189 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSBMUG00000013640
Gene Symbol: TACR1
3 Cross references
271 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSBMUG00000014822
Gene Symbol: TACR2
3 Cross references
200 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSBMUG00000012233
Gene Symbol: TACR3
3 Cross references
258 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSBMUG00000016845
Gene Symbol: TBXAS1
3 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSBMUG00000018072
Gene Symbol: TBXA2R
3 Cross references
194 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSBMUG00000022434
Gene Symbol: TYMS
3 Cross references
223 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSBMUG00000012245
Gene Symbol: THRB
3 Cross references
393 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).